A MOTHER has revealed that despite losing over three stone thanks to Mounjaro, she has been hit with some unfortunate side effects. Chloe Mckernan, 32, a mum-of-two from Glasgow who is currently ...

Constantly being hungry isn’t normal—but experts say there are natural appetite suppressants that can keep your cravings ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Glucagon-like peptide-1 receptor (GLP1) agonists might resolve metabolic dysfunction-associated steatohepatitis, but their effect on hard clinical outcomes in patients with chronic liver diseases of ...

I know we wanna cheat the system as Americans, we do,” the 53-year-old tells Page Six in an exclusive interview.